एपीए उद्धरण

Isono, M., Hoffmann, M. J., Pinkerneil, M., Sato, A., Michaelis, M., Cinatl, J., . . . Schulz, W. A. (2017). Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine. J Exp Clin Cancer Res.

शिकागो स्टाइल उद्धरण

Isono, Makoto, Michèle J. Hoffmann, Maria Pinkerneil, Akinori Sato, Martin Michaelis, Jindrich Cinatl, Günter Niegisch, और Wolfgang A. Schulz. "Checkpoint Kinase Inhibitor AZD7762 Strongly Sensitises Urothelial Carcinoma Cells to Gemcitabine." J Exp Clin Cancer Res 2017.

एमएलए उद्धरण

Isono, Makoto, et al. "Checkpoint Kinase Inhibitor AZD7762 Strongly Sensitises Urothelial Carcinoma Cells to Gemcitabine." J Exp Clin Cancer Res 2017.